Experts urge metabolic screening across psychiatric diagnoses, spotlighting tailored interventions and tools like PsyMetRiC—while warning risk talks can backfire.
Benjamin I. Perry, PhD
Advertisement
Dr Perry is an associate clinical professor of Psychiatry at the University of Birmingham, and a consultant psychiatrist in the Birmingham Early Intervention Services.
Articles by Benjamin I. Perry, PhD
Experts explain why every diagnosis needs metabolic screening, how to discuss risk safely, and when to use tools like PsyMetRiC to assess risk.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults
2
Quiet Comfort: New Details on COMP360 Psilocybin Administration Sessions for the Treatment of PTSD
3
Preventing Alzheimer Disease After Brain Injury: Targeting TNF With XPro1595
4
Phase 2 Topline Results From ZEPHYR Trial: ML-007C-MA for the Treatment of Schizophrenia
5